The S&P/ASX 200 index managed a marginal gain for the 2026 financial year, masking one of the most challenging periods for active stock selection in recent memory.
The market’s narrow advance was driven almost entirely by a surge in resources stocks, which rewarded investors who maintained exposure to the mining sector.
Conversely, those positioned in technology and healthcare faced severe underperformance as these former darlings of the market endured a brutal sell-off throughout the year.
The divergence highlights a sharp rotation in capital flows, where traditional value and commodity plays outperformed growth-oriented equities.
While the headline index posted a positive return, the breadth of the market was weak, with significant losses in high-profile tech and healthcare names dragging down overall sentiment for active managers.
The performance gap underscores the difficulty of navigating a market where sector-specific risks and opportunities diverged so dramatically.